TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1587965

Group type: EXPERIMENTAL
Intervention: 400 mcg triamcinolone acetonide aerosol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 800 mcg triamcinolone acetonide aerosol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1600 mcg triamcinolone acetonide aerosol
Number of subjects: 9
Study: 4004963

Group type: EXPERIMENTAL
Intervention: Five health status instruments administered before and after total joint arthroplasty
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Five health status instruments
Number of subjects: 50
Study: 30773222

Group type: EXPERIMENTAL
Intervention: Cisplatin 40 mg/m2 weekly for up to six doses with 41.4-45 Gy external beam radiation therapy followed by high dose rate brachytherapy
Number of subjects: 40
Study: 29382797

Group type: EXPERIMENTAL
Intervention: GSK1995057 (nebulised TNFR1 antagonist)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 37
Study: 27777220

Group type: EXPERIMENTAL
Intervention: Early ART
Number of subjects: 957

Group type: COMPARATOR
Intervention: Deferred ART
Number of subjects: 957
Study: 25049001

Group type: EXPERIMENTAL
Intervention: Steps per day (incremental increases of 1,000 steps)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Higher step counts
Number of subjects: 199
Study: 21909820

Group type: EXPERIMENTAL
Intervention: Dendritic cell vaccine
Number of subjects: 0
Study: 19415181

Group type: EXPERIMENTAL
Intervention: Temsirolimus 75 mg, administered orally once daily for 5 days every 2 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Temsirolimus 75 mg
Number of subjects: 12
Study: 19260512

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 0
Study: 16380670

Group type: EXPERIMENTAL
Intervention: rosiglitazone (8 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 11896522

Group type: EXPERIMENTAL
Intervention: Warming the heel (Experimental)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No warming (Control)
Number of subjects: 100
Study: 10327731

Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg, twice a day for 3 months
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 48
Study: 8725926

Group type: EXPERIMENTAL
Intervention: Inclinometer technique
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Modified-Schober sign
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Extension lumbar range of motion
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Correlation with gender, age, and body weight
Number of subjects: 29
Study: 1760067

Group type: EXPERIMENTAL
Intervention: Dual agent therapy (ampicillin and gentamicin)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Triple agent therapy (ampicillin, gentamicin, and clindamycin)
Number of subjects: 133
Study: 7037502

Group type: EXPERIMENTAL
Intervention: guanabenz
Number of subjects: 188

Group type: COMPARATOR
Intervention: clonidine
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: guanabenz and hydrochlorothiazide
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: guanabenz or hydrochlorothiazide
Number of subjects: 188
Study: 30782938

Group type: EXPERIMENTAL
Intervention: Safety Planning Intervention (SPI) with telephone follow-up and treatment as usual, n=80
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as usual, n=40
Number of subjects: 120
Study: 28422600

Group type: EXPERIMENTAL
Intervention: Supervised tooth brushing at school once a day after a meal
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 250
Study: 26402830

Group type: EXPERIMENTAL
Intervention: Digital image guidance using VERION digital marker
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual slitlamp‐assisted preoperative marking using pendulum‐attached marker
Number of subjects: 60
Study: 22952203

Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 16
Study: 21299408

Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Repositioning Appliance (MARA)
Number of subjects: 23
Study: 19712254

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Percutaneous intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cardiovascular testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Revascularization of coronary artery stenoses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Myocardial stress test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coronary artery intervention prior to transplantation
Number of subjects: 0
Study: 16707886

Group type: EXPERIMENTAL
Intervention: Intramuscular triamcinolone acetonide (imTA) 40 mg once a month for 6 months followed by 40 mg once every 1.5 months for 1 year (imTA group)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Pulse therapy (PT) using oral prednisone 80 mg for 3 consecutive days once every 3 months (PT group)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Oral dexamethasone (Dex) 0.5 mg/day for 6 months (Dex group)
Number of subjects: 89
Study: 15301776

Group type: EXPERIMENTAL
Intervention: Portable muscle tone measurement device
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 30
Study: 11271956

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 9004056

Group type: EXPERIMENTAL
Intervention: DMI plus Li (N = 16)
Number of subjects: 31

Group type: COMPARATOR
Intervention: DMI plus placebo (N = 15)
Number of subjects: 31
Study: 8431363

Group type: EXPERIMENTAL
Intervention: Qualitator daily diary card for Quality of Life measurement
Number of subjects: 60

Group type: COMPARATOR
Intervention: Linear Analogue Self‐Assessment and Nottingham Health Profile
Number of subjects: 60
Study: 3312789

Group type: EXPERIMENTAL
Intervention: Sequential course of 14 days conventional immunosuppression (Lymphocytoglobulin (ALG), azathioprine, steroids) and cyclosporin and steroids thereafter (group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional immunosuppression for 7 days followed by cyclosporin and steroids (group B)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients with serum creatinine of less than 2 mg/dl at the time of conversion to cyclosporin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Patients with serum creatinine of more than 2 mg/dl at the time of conversion to cyclosporin
Number of subjects: 100
Study: 31425480

Group type: EXPERIMENTAL
Intervention: Vemurafenib plus cobimetinib
Number of subjects: 809

Group type: COMPARATOR
Intervention: Vemurafenib (monotherapy)
Number of subjects: 809
Study: 31394768

Group type: EXPERIMENTAL
Intervention: Hot water extract of Curcuma longa L. (WEC) 900 mg tablets containing 400 μg bisacurone, 80 μg turmeronol A, and 20 μg turmeronol B
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hot water extract of Curcuma longa L. (WEC)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 28607336

Group type: EXPERIMENTAL
Intervention: King Vision™ video laryngoscopy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Macintosh laryngoscopy
Number of subjects: 29
Study: 26799907

Group type: EXPERIMENTAL
Intervention: NO-FEAR Airlines (Computer-aided Self-help Treatment); includes psychoeducation, exposure through 6 scenarios with images and sounds related to flying; self-applied via Internet.
Number of subjects: 0
Study: 24621972

Group type: EXPERIMENTAL
Intervention: CABG plus medical therapy
Number of subjects: 1212

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 1212
Study: 21178832

Group type: EXPERIMENTAL
Intervention: Qigong
Number of subjects: 123

Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 123

Group type: COMPARATOR
Intervention: Waiting list (no treatment)
Number of subjects: 123
Study: 18513463

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg, 3 times daily
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/day
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg, 3 times daily + Ezetimibe 10 mg/day
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 86
Study: 16263768

Group type: EXPERIMENTAL
Intervention: 73% Normoxia
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 72% Hypoxia
Number of subjects: 8

Group type: COMPARATOR
Intervention: 51% Normoxia
Number of subjects: 8
Study: 15069431

Group type: EXPERIMENTAL
Intervention: PACG
Number of subjects: 230

Group type: COMPARATOR
Intervention: POAG
Number of subjects: 230
Study: 11434162

Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Conservative treatment (grade II)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Conservative treatment (grade III)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Conservative treatment (grade I)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 96

Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 96
Study: 9720838

Group type: EXPERIMENTAL
Intervention: 250 mg twice daily zinc therapy for 3 months
Number of subjects: 100
Study: 7727550

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 40
Study: 2902379

Group type: EXPERIMENTAL
Intervention: Berlin‐Frankfurt‐Munster (BFM) 76/79 regimen
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: New York (NY) regimen
Number of subjects: 229

Group type: COMPARATOR
Intervention: Control regimen
Number of subjects: 229
Study: 31012819

Group type: EXPERIMENTAL
Intervention: Exercise Only (EO)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Exercise with Energy Replacement (ER)
Number of subjects: 14

Group type: COMPARATOR
Intervention: No Exercise (NE)
Number of subjects: 14
Study: 31852527

Group type: EXPERIMENTAL
Intervention: Pelvic surgery
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (healthy males)
Number of subjects: 106
Study: 28576285

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine (0.5 mg/kg)
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: High-dose ketamine (1.0 mg/kg)
Number of subjects: 672
Study: 26162735

Group type: EXPERIMENTAL
Intervention: Life-review
Number of subjects: 202

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 202
Study: 23261647

Group type: EXPERIMENTAL
Intervention: Flash of blue light
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Flash of red light
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Flash of white light
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no flash of light)
Number of subjects: 120
Study: 22047811

Group type: EXPERIMENTAL
Intervention: Liquid formulation of dexamethasone (2 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Tablet formulation of dexamethasone (2 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Liquid vs Tablet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pharmacodynamic parameter AUEC
Number of subjects: 24
Study: 19957671

Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Micro-drill treatment
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Laser treatment in PSCO group
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Laser treatment in NLDO group
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Micro-drill treatment in PSCO group
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Micro-drill treatment in NLDO group
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Laser treatment complications
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Micro-drill treatment complications
Number of subjects: 89
Study: 16799342

Group type: EXPERIMENTAL
Intervention: Prone extubation (group P)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Supine extubation (group S)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Supine extubation with intravenous lidocaine (group SL)
Number of subjects: 105
Study: 12763210

Group type: EXPERIMENTAL
Intervention: Fulvestrant (Faslodex)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anastrozole (Arimidex)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fulvestrant (Faslodex) and Anastrozole (Arimidex)
Number of subjects: 0
Study: 10944136

Group type: EXPERIMENTAL
Intervention: CNS involvement at diagnosis (lymphoma cells in the CSF, cranial nerve palsy)
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: CNS involvement at diagnosis
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Elevated serum LDH or higher modified stage
Number of subjects: 445
Study: 9310014

Group type: EXPERIMENTAL
Intervention: Isoniazid (INH)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 28
Study: 8100611

Group type: EXPERIMENTAL
Intervention: Zidovudine (500 mg twice daily)
Number of subjects: 993
Study: 2880655

Group type: EXPERIMENTAL
Intervention: Interferon-beta (IFN-beta)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Interferon-gamma (IFN-gamma)
Number of subjects: 11
Study: 29479645

Group type: EXPERIMENTAL
Intervention: Total daily sitting time
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: More frequent breaks in sitting time
Number of subjects: 123
Study: 26612114

Group type: EXPERIMENTAL
Intervention: White bread with baobab fruit extract (1.88%)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: White bread with green tea extract (0.4%)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control white bread
Number of subjects: 13
Study: 26573101

Group type: EXPERIMENTAL
Intervention: Anterior colporrhaphy (n = 25)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Perigee procedure (n = 76)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Women with Green type III cystocele
Number of subjects: 336
Study: 23535509

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21374904

Group type: EXPERIMENTAL
Intervention: Proximal Femoral Nail Anti-Rotation (PFNA)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Third Generation Gamma Nail (TGN)
Number of subjects: 107
Study: 18087209

Group type: EXPERIMENTAL
Intervention: Active treatment (rTMS)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham stimulation (placebo)
Number of subjects: 14
Study: 15983153

Group type: EXPERIMENTAL
Intervention: ILMA tracheal tube (TT; for LMA‐Fastrach)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard PVC TT (Portex)
Number of subjects: 40
Study: 14667881

Group type: EXPERIMENTAL
Intervention: GnRH antagonist administered from stimulation day 6
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (serum P <1.2 ng/mL)
Number of subjects: 81
Study: 10978402

Group type: EXPERIMENTAL
Intervention: Target Hb of 14 g/dl
Number of subjects: 14

Group type: COMPARATOR
Intervention: Target Hb of 10 g/dl
Number of subjects: 14
Study: 8642853

Group type: EXPERIMENTAL
Intervention: CI-973 at MTD of 1000 mg/m2 per course
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CI-973 at doses > or = 1000 mg/m2
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CI-973 therapy
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CI-973
Number of subjects: 36
Study: 1848289

Group type: EXPERIMENTAL
Intervention: Sintered hydroxyapatite implant material
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 0
Study: 6229864

Group type: EXPERIMENTAL
Intervention: Ipratropium nasal spray
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ipratropium
Number of subjects: 30
Study: 30879732

Group type: EXPERIMENTAL
Intervention: Immediate cord clamping
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Umbilical cord milking
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping
Number of subjects: 45
Study: 29151225

Group type: EXPERIMENTAL
Intervention: Flavanone intake
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Flavone intake
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Anthocyanidins and flavan‐3‐ols
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Anthocyanidins, flavan‐3‐ols and flavonols
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Flavonols
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Flavan‐3‐ols intake
Number of subjects: 78
Study: 26817621

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Disulfiram
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo with no CM
Number of subjects: 99

Group type: COMPARATOR
Intervention: No CM
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: One year follow-up
Number of subjects: 99
Study: 25100363

Group type: EXPERIMENTAL
Intervention: Pramlintide
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 22997783

Group type: EXPERIMENTAL
Intervention: Continuous wave electroacupuncture
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Disperse-dense wave electroacupuncture
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Intermittent wave electroacupuncture
Number of subjects: 129
Study: 19837005

Group type: EXPERIMENTAL
Intervention: Spinal Manipulative Therapy (SMT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Light Massage (LM)
Number of subjects: 80
Study: 17710799

Group type: EXPERIMENTAL
Intervention: Acupuncture plus moxibustion combined with a psychological approach
Number of subjects: 310
Study: 16249724

Group type: EXPERIMENTAL
Intervention: Resilon/Epiphany
Number of subjects: 0

Group type: COMPARATOR
Intervention: gutta-percha/AH Plus
Number of subjects: 0
Study: 12150239

Group type: EXPERIMENTAL
Intervention: Anger elicitation
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Shame elicitation
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Pride elicitation
Number of subjects: 109

Group type: COMPARATOR
Intervention: Neutral opinion-expression task (nonemotion condition)
Number of subjects: 109
Study: 11137053

Group type: EXPERIMENTAL
Intervention: 20-Hz rTMS
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both 20-Hz and 1-Hz rTMS
Number of subjects: 10
Study: 9337606

Group type: EXPERIMENTAL
Intervention: Training in procedural justice
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 71
Study: 1441734

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (3 intramuscular injections at months 0, 1, and 2)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Healthy controls (271 participants, mean age 24.2 years)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine
Number of subjects: 197
Study: 2863799

Group type: EXPERIMENTAL
Intervention: ACC‐9447 (topical beta adrenergic antagonist)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 30321051

Group type: EXPERIMENTAL
Intervention: Stereotypic expectations from multiple perceivers
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Judgments by new perceivers
Number of subjects: 241
Study: 27131029

Group type: EXPERIMENTAL
Intervention: Subperiosteal surgical dissection
Number of subjects: 32

Group type: COMPARATOR
Intervention: Supraperiosteal surgical dissection
Number of subjects: 32
Study: 23929687

Group type: EXPERIMENTAL
Intervention: High concentration olfactory training (OT) for 18 weeks
Number of subjects: 144

Group type: COMPARATOR
Intervention: Low concentration olfactory training (OT) for 18 weeks
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: High concentration olfactory training (OT) for 18 weeks in subjects with <12 months duration of dysfunction
Number of subjects: 144

Group type: COMPARATOR
Intervention: Low concentration olfactory training (OT) for 18 weeks in subjects with <12 months duration of dysfunction
Number of subjects: 144
Study: 24032192

Group type: EXPERIMENTAL
Intervention: Warm needling therapy
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Electroacupuncture therapy
Number of subjects: 136

Group type: COMPARATOR
Intervention: Common acupuncture therapy
Number of subjects: 136
Study: 21358250

Group type: EXPERIMENTAL
Intervention: Dynamic hip screw (DHS)
Number of subjects: 157

Group type: COMPARATOR
Intervention: AO angled blade plate (AP)
Number of subjects: 157
Study: 18543482

Group type: EXPERIMENTAL
Intervention: Abdominal needling (AN) applied at Xiawan (Ren 10), Qihai (Ren 6), Qipang, Guanyuan (Ren 4), Qixue, Shuifen (Ren 9), Tianshu (St. 25) and Daju (St. 27), starting from the first day after operation, once every day for 5 days with needle retained for 20 min.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group treated with intravenous injection of 20 mg Omeprazole once a day for 3 successive days.
Number of subjects: 60
Study: 16415703

Group type: EXPERIMENTAL
Intervention: Sertraline (25 mg/d for 1 week, then 50 mg/d for 15 weeks)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 76
Study: 12790861

Group type: EXPERIMENTAL
Intervention: Open-tracheal suction
Number of subjects: 47

Group type: COMPARATOR
Intervention: Closed-tracheal suction
Number of subjects: 47
Study: 10818030

Group type: EXPERIMENTAL
Intervention: Anticoagulation treatment (warfarin) after individualised decision analysis
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Decision analysis
Number of subjects: 260

Group type: COMPARATOR
Intervention: Warfarin prescription
Number of subjects: 260
Study: 8867905

Group type: EXPERIMENTAL
Intervention: GL-METF (2.5 mg glibenclamide and 400 mg metformin)
Number of subjects: 30

Group type: COMPARATOR
Intervention: GL-PHEN (2.5 mg glibenclamide and 25 mg phenformin)
Number of subjects: 30
Study: 1502356

Group type: EXPERIMENTAL
Intervention: Plain abdominal radiographs
Number of subjects: 97
Study: 29366513

Group type: EXPERIMENTAL
Intervention: Vibegron 50mg once daily
Number of subjects: 1232

Group type: EXPERIMENTAL
Intervention: Vibegron 100mg once daily
Number of subjects: 1232

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1232

Group type: EXPERIMENTAL
Intervention: Imidafenacin 0.1mg twice daily
Number of subjects: 1232
Study: 27006266

Group type: EXPERIMENTAL
Intervention: Decremental target minute ventilation (DTMV)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Constant target minute ventilation
Number of subjects: 52